首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Protein myristoylation in health and disease
Authors:Megan H Wright  William P Heal  David J Mann  Edward W Tate
Institution:(1) Chemical Biology Centre, Imperial College London, Exhibition Rd., London, SW72AZ, UK;(2) Department of Chemistry, Imperial College London, Exhibition Rd., London, SW72AZ, UK;(3) Department of Life Sciences, Imperial College London, Exhibition Rd., London, SW72AZ, UK;
Abstract:N-myristoylation is the attachment of a 14-carbon fatty acid, myristate, onto the N-terminal glycine residue of target proteins, catalysed by N-myristoyltransferase (NMT), a ubiquitous and essential enzyme in eukaryotes. Many of the target proteins of NMT are crucial components of signalling pathways, and myristoylation typically promotes membrane binding that is essential for proper protein localisation or biological function. NMT is a validated therapeutic target in opportunistic infections of humans by fungi or parasitic protozoa. Additionally, NMT is implicated in carcinogenesis, particularly colon cancer, where there is evidence for its upregulation in the early stages of tumour formation. However, the study of myristoylation in all organisms has until recently been hindered by a lack of techniques for detection and identification of myristoylated proteins. Here we introduce the chemistry and biology of N-myristoylation and NMT, and discuss new developments in chemical proteomic technologies that are meeting the challenge of studying this important co-translational modification in living systems.
Keywords:Post-translational modification  Drug design  Myristoylation  Lipidation  Chemical proteomics
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号